Neoadjuvant immunotherapy for DNA mismatch repair proficient/microsatellite stable non-metastatic rectal cancer: a systematic review and meta-analysis
BackgroundNeoadjuvant immunotherapy (NIT) has been endorsed by clinical guidelines for the management of DNA mismatch repair deficiency/microsatellite instability-high (dMMR/MSI-H) locally advanced rectal cancer (LARC). Nonetheless, the therapeutic efficacy of NIT in mismatch repair-proficient/micro...
Saved in:
Main Authors: | Huan Zhang, Jing Huang, Huanji Xu, Nanhao Yin, Liyan Zhou, Jianxin Xue, Min Ren |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1523455/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact on CD4+ CD25High-CD127low regulatory T (Treg) cells of neoadjuvant therapy for rectal cancer patients
by: Liu Maoxi, et al.
Published: (2023-07-01) -
Role of mast cell in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy
by: Masaaki Nishi, et al.
Published: (2025-01-01) -
Computed Tomography Scan and Clinical-based Complete Response Prediction in Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy: A Machine Learning Approach
by: Seyyed Hossein Mousavie Anijdan, et al.
Published: (2024-12-01) -
The characteristics of the tumor immune microenvironment in colorectal cancer with different MSI status and current therapeutic strategies
by: Qingzhe Wang, et al.
Published: (2025-01-01) -
Organ Function Preservation in Locally Advanced Low Rectal Cancer Through Total Neoadjuvant Therapy: A Case Report and Literature Review
by: Liu F, et al.
Published: (2025-01-01)